Lyon RA[au] - Search Results

Year	Number of Results
1939	1
1945	1
1946	9
1947	1
1949	1
1952	2
1953	2
1954	3
1955	1
1956	2
1958	2
1967	1
1984	2
1985	5
1986	7
1987	4
1988	8
1989	6
1990	4
1992	1
1994	1
2004	1
2009	1
2010	1
2016	1
2018	1
2024	0

1

Clinical efficacy and safety of evolocumab for low-density lipoprotein cholesterol reduction.

Henry CA, Lyon RA, Ling H. Henry CA, et al. Among authors: lyon ra. Vasc Health Risk Manag. 2016 Apr 19;12:163-9. doi: 10.2147/VHRM.S82387. eCollection 2016. Vasc Health Risk Manag. 2016. PMID: 27143910 Free PMC article. Review.

2

In vitro pharmacology of ambroxol: Potential serotonergic sites of action.

Hull JD, Lyon RA. Hull JD, et al. Among authors: lyon ra. Life Sci. 2018 Mar 15;197:67-72. doi: 10.1016/j.lfs.2018.02.002. Epub 2018 Feb 3. Life Sci. 2018. PMID: 29412172

3

Endocardial sclerosis.

BLUMBERG RW, LYON RA. BLUMBERG RW, et al. Among authors: lyon ra. AMA Am J Dis Child. 1952 Sep;84(3):291-308. doi: 10.1001/archpedi.1952.02050030017001. AMA Am J Dis Child. 1952. PMID: 14952006 No abstract available.

4

Arylpiperazine derivatives as high-affinity 5-HT1A serotonin ligands.

Glennon RA, Naiman NA, Lyon RA, Titeler M. Glennon RA, et al. Among authors: lyon ra. J Med Chem. 1988 Oct;31(10):1968-71. doi: 10.1021/jm00118a018. J Med Chem. 1988. PMID: 3172131

5

N-methyl derivatives of the 5-HT2 agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane.

Glennon RA, Titeler M, Seggel MR, Lyon RA. Glennon RA, et al. Among authors: lyon ra. J Med Chem. 1987 May;30(5):930-2. doi: 10.1021/jm00388a032. J Med Chem. 1987. PMID: 3572981

6

Anomalous origin of the left coronary artery.

LYON RA, JOHANSMANN RJ, DODD K. LYON RA, et al. Am J Dis Child (1911). 1946 Dec;72(6):675-90. doi: 10.1001/archpedi.1946.02020350042004. Am J Dis Child (1911). 1946. PMID: 20280328 No abstract available.

7

Asymmetry in D-2 binding in female rat striata.

Drew KL, Lyon RA, Titeler M, Glick SD. Drew KL, et al. Among authors: lyon ra. Brain Res. 1986 Jan 15;363(1):192-5. doi: 10.1016/0006-8993(86)90678-5. Brain Res. 1986. PMID: 2936425

8

5-HT1 and 5-HT2 binding characteristics of 1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane analogues.

Glennon RA, McKenney JD, Lyon RA, Titeler M. Glennon RA, et al. Among authors: lyon ra. J Med Chem. 1986 Feb;29(2):194-9. doi: 10.1021/jm00152a005. J Med Chem. 1986. PMID: 3950904

9

3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors.

Lyon RA, Glennon RA, Titeler M. Lyon RA, et al. Psychopharmacology (Berl). 1986;88(4):525-6. doi: 10.1007/BF00178519. Psychopharmacology (Berl). 1986. PMID: 2871581

10

A role for histamine and H2-receptors in opioid antinociception.

Gogas KR, Hough LB, Eberle NB, Lyon RA, Glick SD, Ward SJ, Young RC, Parsons ME. Gogas KR, et al. Among authors: lyon ra. J Pharmacol Exp Ther. 1989 Aug;250(2):476-84. J Pharmacol Exp Ther. 1989. PMID: 2547933

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

68 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year